Jul 2021 $1 M No. 11 Under $2 million 2
Cynvenio Biosystems LLC: Raise no. 11, Jul 2021 × Investors in this round 2 investors had bought by the notice of Jul 16, 2021: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Anderson · Executive Officer, Director Paul Pagano · Executive Officer, Director Andrew Roy Boteler · Director Gordon Roy Davis · Director James McCullough · Director Sara Roy Barrington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Paul Pagano, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 16, 2021. Read the notice at the SEC .
equity SEC Jul 2021 $3 M No. 10 $2 to $10 million 2
Cynvenio Biosystems LLC: Raise no. 10, Jul 2021 × Investors in this round 2 investors had bought by the notice of Jul 15, 2021: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Paul Anderson · Executive Officer, Director Paul Pagano · Executive Officer, Director Gordon Roy Davis · Director James McCullough · Director Sara Roy Barrington · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Paul Pagano, Ceo. Source: SEC Form D, newest notice filed Jul 15, 2021. Read the notice at the SEC .
options SEC Oct 2017 $10 M No. 9 $10 to $50 million 35
Cynvenio Biosystems LLC: Raise no. 9, Oct 2017 × Investors in this round 35 investors had bought by the notice of May 26, 2021: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $12 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, other: Convertible Secured Promissory Note; Warrant Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Anderson · Executive Officer · Chief Financial Officer Michael Pfau · Executive Officer · Secretary Paul Pagano · Executive Officer, Director · Chief Executive Officer Frederick Gluck · Director James McCullough · Director Jianing Liu · Director Justin Xiang · Director Simon Raab · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Paul Pagano, Ceo. Source: SEC Form D and 8 amendments, newest notice filed May 26, 2021. Read the notice at the SEC .
debt, options SEC May 2015 $25 M No. 8 $10 to $50 million 41
Cynvenio Biosystems LLC: Raise no. 8, May 2015 × Investors in this round 41 investors had bought by the notice of Jun 4, 2015: 41 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them, other: Note Conversion and Series B Preferred Stock Agreement Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre de Fusco · Executive Officer, Director · Chief Executive Officer Michael de Pfau · Executive Officer · Secretary Alan de Heeger · Director Daotian de Fu, Ph.D · Director Frederick de Gluck · Director Paul de Billings · Director Simon de Raab · Director YuCai de Peng, Ph.D · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds will be used for working capital by the Company.”Signed by Michael E. Pfau, Secretary. Source: SEC Form D, newest notice filed Jun 4, 2015. Read the notice at the SEC .
equity SEC Jul 2014 $3 M No. 7 $2 to $10 million 23
Cynvenio Biosystems LLC: Raise no. 7, Jul 2014 × Investors in this round 23 investors had bought by the notice of Sep 2, 2014: 23 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, other: Convertible Secured Note and Warrant Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre De Fusco · Executive Officer, Director · Chief Executive Officer Michael Pfau · Executive Officer · Secretary Alan Heeger · Director Frederick Gluck · Director Simon Raab · Director Tom Hyongsok Soh · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds used for working capital.”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 2 amendments, newest notice filed Sep 2, 2014. Read the notice at the SEC .
debt, options SEC Nov 2013 $1 M No. 6 Under $2 million 3
Cynvenio Biosystems LLC: Raise no. 6, Nov 2013 × Investors in this round 3 investors had bought by the notice of Jan 28, 2014: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series B-4 Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre de Fusco · Executive Officer, Director · Chief Executive Officer Michael Pfau · Executive Officer · Secretary Alan Heeger · Director Amit Munshi · Director Frederick Gluck · Director Simon Raab · Director Tom Hyongsok Soh · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds used for working capital.”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jan 28, 2014. Read the notice at the SEC .
equity SEC Jun 2013 $3 M No. 5 $2 to $10 million 2
Cynvenio Biosystems LLC: Raise no. 5, Jun 2013 × Investors in this round 2 investors had bought by the notice of Oct 18, 2013: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Note and Warrant offering Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre de Fusco · Executive Officer, Director · Chief Executive Officer Michael Pfau · Executive Officer · Secretary Alan Heeger · Director Amit Munshi · Director Frederick Gluck · Director Simon Raab · Director Tom Hyongsok Soh · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds to be used for working capital.”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 4 amendments, newest notice filed Oct 18, 2013. Read the notice at the SEC .
debt, options SEC Jun 2012 $3 M No. 4 $2 to $10 million 15
Cynvenio Biosystems LLC: Raise no. 4, Jun 2012 × Investors in this round 15 investors had bought by the notice of Nov 26, 2012: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Series B-4 Preferred Stock and Warrant
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre de Fusco · Executive Officer, Director · Chief Executive Officer and President Michael Pfau · Executive Officer · Secretary Paul Meyer · Executive Officer · Chief Financial Officer Alan Heeger · Director Amit Munshi · Director Frederick Gluck · Director Harry Gelles · Director Simon Raab · Director Tom Hyhongsok Soh · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds used for working capital.”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 3 amendments, newest notice filed Nov 26, 2012. Read the notice at the SEC .
equity, options SEC Nov 2011 $3 M No. 3 $2 to $10 million 25
Cynvenio Biosystems LLC: Raise no. 3, Nov 2011 × Investors in this round 25 investors had bought by the notice of May 7, 2012: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Note and Warrant Offering
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre de Fusco · Executive Officer, Director · President and Chief Executive Officer Michael Pfau · Executive Officer · Secretary Paul Meyer · Executive Officer · Chief Financial Officer Alan Heeger · Director Amit Munshi · Director Frederick Gluck · Director Simon Raab · Director Tom Hyongsok Soh · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds to be used for working capital.”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 1 amendment, newest notice filed May 7, 2012. Read the notice at the SEC .
debt, options SEC Aug 2010 $2 M No. 2 Under $2 million 1
Cynvenio Biosystems LLC: Raise no. 2, Aug 2010 × Investors in this round 1 investor had bought by the notice of May 24, 2011: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, other: Convertible Note and Warrant Offering
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andre Fusco · Executive Officer, Director · President Michael Pfau · Executive Officer · Secretary Paul Meyer · Executive Officer · Chief Financial Officer Alan Heeger · Director Frederick Gluck · Director Harry Gelles · Director Tom Hyongsok Soh · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Proceeds to be used for working capital”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 2 amendments, newest notice filed May 24, 2011. Read the notice at the SEC .
debt, options SEC May 2009 $2 M No. 1 Under $2 million 1
Cynvenio Biosystems LLC: Raise no. 1, May 2009 × Investors in this round 1 investor had bought by the notice of Jan 11, 2010: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series B Preferred Stock
Meant to last a year or less
Issuer's revenue not stated
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Andre de Fusco · Executive Officer · President and Manager Michael E. Pfau · Executive Officer · Secretary Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital”Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 6 amendments, newest notice filed Jan 11, 2010. Read the notice at the SEC .
equity SEC